Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vishwajeth Bhoopalam

Interventional Cardiology Lincoln, NE Medical Doctor

NPI 1831119841 CMS profile 219142

6940 Van Dorn St Ste 201, Lincoln, NE 68506

Open in the dashboard

General payments

$3,074

48 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vishwajeth Bhoopalam of Lincoln, NE is reported in the CMS Open Payments database as having received $3,074 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 27th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15 2
2024 General $39 2
2023 General $17 1
2022 General $17 1
2021 General $360 12
2020 General $116 2
2019 General $2,511 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vishwajeth Bhoopalam
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Vishwajeth Bhoopalam were reported at $15. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Vishwajeth Bhoopalam Interventional Cardiology median Middle half National median
2019 $2,511 $1,097 $329–$3,048 $163
2020 $116 $473 $161–$1,480 $114
2021 $360 $677 $233–$1,827 $132
2022 $17 $978 $333–$2,724 $149
2023 $17 $1,136 $382–$2,986 $160
2024 $39 $1,181 $395–$3,326 $164
2025 $15 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $2,359 18 payments
  2. Astellas Pharma US Inc $342 4 payments
  3. Medtronic, Inc. $53 3 payments
  4. Novartis Pharmaceuticals Corporation $46 3 payments
  5. Gilead Sciences, Inc. $40 3 payments
  6. E.R. Squibb & Sons, L.L.C. $40 3 payments
  7. Janssen Pharmaceuticals, Inc $28 2 payments
  8. AstraZeneca Pharmaceuticals LP $27 2 payments
  9. Pfizer Inc. $26 2 payments
  10. Biotronik Inc. $22 1 payment
  11. Other $90 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $1,759 6 payments
  2. Food and Beverage $973 38 payments
  3. Education $342 4 payments
Products named General payments · program years 2019–2025
  1. VenaSeal EndoVenous Therapies $2,333 16 payments
  2. ENTRESTO $46 3 payments
  3. ELIQUIS Cardiovascular $40 3 payments
  4. VENASEAL EndoVenous Therapies $39 2 payments
  5. XARELTO $28 2 payments
  6. ELIQUIS Cardiovascular;Metabolic Disease $26 2 payments
  7. VYNDAQEL $26 2 payments
  8. VIABAHN VBX Balloon Expandable Endoprosthesis $19 1 payment
  9. WatchPAT $17 1 payment
  10. Cardiva VASCADE 6/7F VCS $17 1 payment
  11. Other $102 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$18,441

Medicare's payments for the services billed

Medicare patients

156

Average age 74

Services billed

290

78 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 70%
Diabetes 54%
Heart failure 54%
Arthritis 50%
Atrial fibrillation 42%
COPD 39%
Chronic kidney disease 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Nebraska

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record